D-0129-2023 Class II Terminated

Recalled by Fresenius Kabi USA, LLC — Lake Zurich, IL

Recall Details

Product Type
Drugs
Report Date
January 25, 2023
Initiation Date
November 22, 2022
Termination Date
October 23, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31,600 vials

Product Description

Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 25 mg per 10 mL (2.5 mg per mL), 10 mL Single Dose Vial (NDC 63323-468-01), packaged in 25 Single Dose Vials per tray (NDC 63323-468-17), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Reason for Recall

Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Distribution Pattern

Nationwide in the USA

Code Information

Batch #: 6128800, exp 12/2023